Scleroderma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
===Race=== | ===Race=== | ||
* | *Choctaw native americans from southeastern Oklahoma were reported to have much higher prevalence of scleroderma than the general population.<ref name="pmid8702445">{{cite journal |vauthors=Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD |title=Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype |journal=Arthritis Rheum. |volume=39 |issue=8 |pages=1362–70 |date=August 1996 |pmid=8702445 |doi= |url=}}</ref> | ||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | *[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | ||
===Gender=== | ===Gender=== | ||
*Females are more commonly affected by scleroderma than males. The female to male ratio is approximately 4 to 1.<ref name="urlSystemic scleroderma - Genetics Home Reference-US national library of medicine">{{cite web |url=https://ghr.nlm.nih.gov/condition/systemic-scleroderma#sourcesforpage |title=Systemic scleroderma - Genetics Home Reference |format= |work= |accessdate=}}</ref> | *Females are more commonly affected by scleroderma than males. The female to male ratio is approximately 4 to 1.<ref name="urlSystemic scleroderma - Genetics Home Reference-US national library of medicine">{{cite web |url=https://ghr.nlm.nih.gov/condition/systemic-scleroderma#sourcesforpage |title=Systemic scleroderma - Genetics Home Reference |format= |work= |accessdate=}}</ref> | ||
Revision as of 19:18, 28 March 2018
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Scleroderma epidemiology and demographics |
|
Risk calculators and risk factors for Scleroderma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of scleroderma is approximately 2 per 100,000 individuals in the United States.[1]
Prevalence
- The prevalence of scleroderma is approximately 24 cases per 100,000 individuals in the United States.[2]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- Choctaw native americans from southeastern Oklahoma were reported to have much higher prevalence of scleroderma than the general population.[3]
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Females are more commonly affected by scleroderma than males. The female to male ratio is approximately 4 to 1.[4]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Mayes MD (May 2003). "Scleroderma epidemiology". Rheum. Dis. Clin. North Am. 29 (2): 239–54.
- ↑ Mayes MD (May 2003). "Scleroderma epidemiology". Rheum. Dis. Clin. North Am. 29 (2): 239–54. PMID 12841293.
- ↑ Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD (August 1996). "Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype". Arthritis Rheum. 39 (8): 1362–70. PMID 8702445.
- ↑ "Systemic scleroderma - Genetics Home Reference".